CLYM · Climb Bio, Inc. · Exempt Offerings
$8.87
-0.46 (-4.93%)
At close · Nov 5
Return incl. dividend (before tax)
Market Cap
$521.01M
Shares
58.74M
Volume · Nov 5
1.44M
Avg daily vol (3M)
1.41M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-05-04 | New | Biotechnology | $110,076,289 | $110,076,289 | 06b |
| 2024-07-02 | New | Biotechnology | $41,867,154 | $41,867,154 | 06b |
| 2024-07-02 | New | Biotechnology | $119,999,986 | $119,999,986 | 06b |
| 2021-05-28 | New | Pharmaceuticals | $59,999,987 | $59,999,987 | 06b |
| 2020-11-03 | New | Pharmaceuticals | $49,999,985 | $4,999,995 | 06b |
Showing 1–5 of 5 filings
Key facts
CIK
1768446
CUSIP
28658R106
13F (30d)
30 filings
26 filers
Visit website
Investor relations